Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Placebo or Haloperidol in Manic Bipolar I
NCT00253162Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in bipolar I disorder, sponsored by Johnson & Johnson. Started Mar 2001; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00253162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253162.